Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
+$972M |
| 2 |
Cisco
CSCO
|
+$610M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$572M |
| 4 |
International Flavors & Fragrances
IFF
|
+$492M |
| 5 |
Mastercard
MA
|
+$400M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
DuPont de Nemours
DD
|
+$563M |
| 3 |
Qualcomm
QCOM
|
+$372M |
| 4 |
Merck
MRK
|
+$332M |
| 5 |
Microsoft
MSFT
|
+$305M |
Sector Composition
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.99% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.55% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBN
2926
DELISTED
Evans Bancorp Inc
EVBN
| $804K | ﹤0.01% |
23,736
+1,799
| +8% | +$60.9K |
|
|
CWBC
2927
Community West Bancshares
CWBC
$416M
| $798K | ﹤0.01% |
43,357
-2,319
| -5% | -$42.7K |
|
2928
Western New England Bancorp
WNEB
$254M
| $798K | ﹤0.01% |
94,725
-6,079
| -6% | -$51.2K |
|
2929
Ituran Location and Control
ITRN
$718M
| $795K | ﹤0.01% |
37,455
+14,739
| +65% | +$313K |
|
2930
Richmond Mutual Bancorp
RMBI
$144M
| $790K | ﹤0.01% |
58,243
-2,273
| -4% | -$30.8K |
|
2931
Wave Life Sciences
WVE
$1.1B
| $788K | ﹤0.01% |
140,604
-8,781
| -6% | -$49.2K |
|
|
CKPT
2932
DELISTED
Checkpoint Therapeutics
CKPT
| $786K | ﹤0.01% |
25,018
+759
| +3% | +$23.8K |
|
2933
BCB Bancorp
BCBP
$151M
| $785K | ﹤0.01% |
56,854
-3,033
| -5% | -$41.9K |
|
2934
eGain
EGAN
$242M
| $782K | ﹤0.01% |
82,360
-2,852
| -3% | -$27.1K |
|
2935
Nathan's Famous
NATH
$438M
| $782K | ﹤0.01% |
12,387
-319
| -3% | -$20.1K |
|
|
OPTN
2936
DELISTED
OptiNose
OPTN
| $781K | ﹤0.01% |
14,108
-2,036
| -13% | -$113K |
|
2937
Investar Holding Corp
ISTR
$230M
| $779K | ﹤0.01% |
37,931
-1,190
| -3% | -$24.4K |
|
2938
South Plains Financial
SPFI
$662M
| $779K | ﹤0.01% |
34,265
-953
| -3% | -$21.7K |
|
|
TCDA
2939
DELISTED
Tricida, Inc. Common Stock
TCDA
| $779K | ﹤0.01% |
147,290
+13,956
| +10% | +$73.8K |
|
|
FRBK
2940
DELISTED
Republic First Bancorp Inc
FRBK
| $778K | ﹤0.01% |
206,357
-8,058
| -4% | -$30.4K |
|
2941
4D Molecular Therapeutics
FDMT
$334M
| $769K | ﹤0.01% |
+17,731
| New | +$769K |
|
2942
Oil-Dri
ODC
$1B
| $769K | ﹤0.01% |
44,660
-3,030
| -6% | -$52.2K |
|
|
KIN
2943
DELISTED
Kindred Biosciences, Inc.
KIN
| $769K | ﹤0.01% |
154,713
-4,021
| -3% | -$20K |
|
2944
Gaia
GAIA
$151M
| $765K | ﹤0.01% |
64,388
+11,271
| +21% | +$134K |
|
2945
Cabaletta Bio
CABA
$197M
| $759K | ﹤0.01% |
68,401
+59
| +0.1% | +$655 |
|
|
LX
2946
LexinFintech Holdings
LX
$961M
| $759K | ﹤0.01% |
75,400
-3,800
| -5% | -$38.3K |
|
2947
Avalo Therapeutics
AVTX
$152M
| $758K | ﹤0.01% |
87
+27
| +45% | +$235K |
|
|
TYME
2948
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $758K | ﹤0.01% |
426,196
+47,420
| +13% | +$84.3K |
|
2949
Fidelity D&D Bancorp
FDBC
$268M
| $757K | ﹤0.01% |
12,303
-602
| -5% | -$37K |
|
2950
Transcat
TRNS
$702M
| $757K | ﹤0.01% |
15,421
-1,564
| -9% | -$76.8K |
|